Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fay Vlasseros"'
Autor:
Adrian Moore, Yongming Gao, Chris Paszty, Fay Vlasseros, Jianhua Gong, Barbara Tipton, Daniel John Lightwood, Alistair James Henry, Jacquelin Jolette, M. D. Hale, Jin Cao, Susan Y. Smith, Michael S. Ominsky, W. Scott Simonet, George Doellgast, David L. Lacey, Jill Cai, Brian Stouch, Rohini Deshpande, Andrew George Popplewell, Lei Zhou, Martyn K. Robinson, Kevin Graham
Publikováno v:
Journal of Bone and Mineral Research. 25:948-959
The development of bone-rebuilding anabolic agents for treating bone-related conditions has been a long-standing goal. Genetic studies in humans and mice have shown that the secreted protein sclerostin is a key negative regulator of bone formation. M
Autor:
Mauricio Barrero, Fay Vlasseros, Xiaodong Li, Chun-Ya Han, Jacquelin Jolette, Edward Lee, Denise Dwyer, Chaoyang Li, David L. Lacey, Susan Y. Smith, Chris Paszty, Franklin J. Asuncion, William S. Simonet, Michael S. Ominsky, Marina Stolina, Gang Li, Hong L Tan, Hua Z. Ke, Rana Samadfam
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 26(5)
Therapeutic enhancement of fracture healing would help to prevent the occurrence of orthopedic complications such as nonunion and revision surgery. Sclerostin is a negative regulator of bone formation, and treatment with a sclerostin monoclonal antib
Publikováno v:
Bone. 49(3)
A novel approach to menopausal therapy is the tissue selective estrogen complex (TSEC) that partners bazedoxifene (BZA) with conjugated estrogens (CE). We examined the effects of daily treatment with BZA 0.3mg/kg, CE 2.5mg/kg, or combined BZA/CE (BZA